Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.

about

Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.

Item

http://www.wikidata.org/entity/Q40608363

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Implications of a switch to a ...... nors: a risk benefit analysis.

@en

type

Item

label

Implications of a switch to a ...... nors: a risk benefit analysis.

@en

prefLabel

Implications of a switch to a ...... nors: a risk benefit analysis.

@en

P1476

Implications of a switch to a ...... nors: a risk benefit analysis.

@en

P2093

A Greinacher

http://www.w3.org/2001/XMLSchema#string

J Bux

http://www.w3.org/2001/XMLSchema#string

T Alt-Mayer

http://www.w3.org/2001/XMLSchema#string

T Thiele

http://www.w3.org/2001/XMLSchema#string

P2860

[Infection epidemiological data among blood donors in Germany 2003-2004. Report of the Robert Koch Institute in accordance with Article 22 of the Transfusion Act].

Moderate and severe adverse events associated with apheresis donations: incidences and risk factors.

Namibia's transition from whole blood-derived pooled platelets to single-donor apheresis platelet collections

Transfusion strategies for acute upper gastrointestinal bleeding.

[HIV, HCV, HBV and syphilis surveillance among blood donors in Germany 2008-2010].

Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks.

Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?

Estimating the residual risk for HIV, HCV and HBV in different types of platelet concentrates in Germany.

Recipients of blood or blood products "at vCJD risk".

Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia.

P304

350-356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/VOX.12433

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27432635

http://www.w3.org/2001/XMLSchema#string